Can I drink alcohol during Ritlecitinib treatment?
Ritlecitinib is a JAK3 and TEC family kinase inhibitor, mainly used to treat autoimmune-related diseases such as severe alopecia areata (hair loss spots). The drug controls inflammation and improves symptoms by suppressing abnormally active immune responses. Due to its strong immunomodulatory effect, many aspects of living habits need to be paid attention to during treatment, including issues such as diet, work and rest, and medication coordination.
Regarding the question of whether drinking alcohol is allowed, the current instructions for ritexitinib do not explicitly prohibit drinking alcohol, but this does not mean that drinking alcohol is a completely safe choice. The reason is that ritexitinib is mainly metabolized by the liver, and alcohol also relies on the liver for detoxification. When the two coexist, they may increase the burden on the liver and increase the risk of abnormal liver function, hepatotoxicity, or drug interactions. In particular, patients with a history of liver disease need to be more cautious.
In addition, ritexitinib treatment may affect the normal function of the immune system and reduce the body's resistance to infection. Alcohol itself also has a certain immunosuppressive effect. Excessive drinking will further weaken immunity and increase the risk of infection, especially in patients receiving long-term immunosuppressive treatment. It is more likely to cause adverse reactions. Therefore, even though occasional small amounts of alcohol may not have immediate serious consequences, frequent or large amounts are not recommended.
Taken together, drinking alcohol should be avoided as much as possible during ritixitinib treatment, especially in the early stages of starting medication or when liver function has not yet been clearly stabilized. If you really need to drink alcohol, it is recommended to consult a doctor first and make a judgment based on your personal physical condition, medication time and liver function indicators to ensure maximum treatment effect and avoid potential risks.
Reference materials:https://www.litfulo.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)